Clinical Trial Update: hepatomiR cACLD Study

View source ↗

Summary

The hepatomiR cACLD clinical trial, sponsored by Karl Landsteiner University of Health Sciences, is currently recruiting for chronic liver disease, cirrhosis, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Liver Disease
• Portal Hypertension

Snippet

Sponsor: Karl Landsteiner University of Health Sciences | Conditions: Chronic Liver Disease and Cirrhosis, Chronic Liver Disease | Status: RECRUITING